Home › RegulatoryAtara Biotherapeutics, Inc. - 10-Q FilingAtara Biotherapeutics reports quarterly results for the period ended September 30, 2026SEC EDGAR · November 10, 2026, 21:15 UTCTickers: $ATRA Read the full article at SEC EDGAR